Shelly Glenn, Director National Accounts at Natera, shared a post on LinkedIn:
“Join us on Saturday, June 27th from 9 AM-12 PM at Hotel Carmichael (breakfast provided) for a focused, multidisciplinary program on how ctDNA and MRD testing are reshaping recurrence detection, therapy decisions, and surveillance strategies.
What to expect:
- The unique utility of MRD testing across specialties in colorectal cancer
- Practical approaches for integrating MRD into clinical workflows
- Strategies for discussing MRD results with colleagues and patients
Physicians and clinicians in the greater Indianapolis area are invited to register and attend. We look forward to an engaging and practical discussion that supports high-quality community oncology care.”
Other articles about Natera on OncoDaily.